|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 440.60 USD | +1.14% |
|
+1.04% | -2.77% |
| Capitalization | 111B 93.87B 86.37B 81.74B 151B 10,254B 154B 1,012B 397B 4,970B 416B 407B 17,518B | P/E ratio 2026 * |
24.9x | P/E ratio 2027 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise value | 97.71B 82.77B 76.16B 72.08B 134B 9,041B 136B 892B 350B 4,383B 367B 359B 15,447B | EV / Sales 2026 * |
7.5x | EV / Sales 2027 * | 6.5x |
| Free-Float |
99.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +1.14% | ||
| 1 week | +1.04% | ||
| Current month | -1.29% | ||
| 1 month | -4.69% | ||
| 3 months | -0.29% | ||
| 6 months | +5.76% | ||
| Current year | -2.77% |
| 1 week | 431.15 |  | 447.82 |
| 1 month | 425.26 | | 463.96 |
| Current year | 425.26 | | 507.92 |
| 1 year | 362.5 | | 510.77 |
| 3 years | 316.43 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 10/04/2019 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 2.32% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.14% | +1.04% | -9.88% | +34.50% | 111B | |
| +2.15% | -1.56% | +10.11% | +148.38% | 809B | |
| +0.08% | -1.44% | +49.25% | +41.86% | 565B | |
| +0.62% | +1.16% | +21.60% | +30.51% | 370B | |
| +0.78% | -0.35% | +24.06% | +13.94% | 320B | |
| +1.72% | -0.74% | +49.33% | +27.86% | 312B | |
| +1.97% | -3.01% | +50.97% | +2.39% | 285B | |
| +1.19% | -2.41% | +31.10% | +34.87% | 286B | |
| +1.80% | +1.29% | +28.22% | +43.32% | 189B | |
| +1.24% | +8.21% | -33.23% | -55.23% | 180B | |
| Average | +1.20% | -1.72% | +22.15% | +32.24% | 342.52B | |
| Weighted average by Cap. | +1.22% | -2.44% | +25.91% | +52.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.02B 11.03B 10.15B 9.61B 17.81B 1,205B 18.12B 119B 46.62B 584B 48.86B 47.84B 2,059B | 14.36B 12.16B 11.19B 10.59B 19.63B 1,328B 19.97B 131B 51.38B 644B 53.85B 52.73B 2,269B |
| Net income | 4.5B 3.81B 3.51B 3.32B 6.15B 416B 6.26B 41.06B 16.1B 202B 16.87B 16.52B 711B | 5.17B 4.38B 4.03B 3.81B 7.07B 478B 7.19B 47.19B 18.5B 232B 19.39B 18.99B 817B |
| Net Debt | -13.1B -11.1B -10.21B -9.66B -17.91B -1,212B -18.22B -120B -46.89B -588B -49.14B -48.12B -2,071B | -17.51B -14.83B -13.65B -12.92B -23.94B -1,620B -24.36B -160B -62.67B -785B -65.68B -64.31B -2,768B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/04/26 | 440.94 $ | +1.21% | 354,075 |
| 16/04/26 | 435.65 $ | -1.37% | 1,364,285 |
| 15/04/26 | 441.70 $ | -0.58% | 1,459,489 |
| 14/04/26 | 444.28 $ | +0.96% | 1,445,501 |
| 13/04/26 | 440.05 $ | +0.87% | 1,004,739 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition